Obdulia Covarrubias-Zambrano, Jing Yu and Stefan H. Bossmann* Pages 379 - 400 ( 22 )
Nano-inspired technologies offer unique opportunities to treat numerous diseases by using therapeutic peptides. Therapeutic peptides have attractive pharmacological profiles and can be manufactured at relatively low costs. The major advantages of using a nanodelivery approach comprises significantly lower required dosages compared to systemic delivery, and thus reduced toxicity and immunogenicity. The combination of therapeutic peptides with delivery peptides and nanoparticles or small molecule drugs offers systemic treatment approaches, instead of aiming for single biological targets or pathways. This review article discusses exemplary state-of-the-art nanosized delivery systems for therapeutic peptides and antibodies, as well as their biochemical and biophysical foundations and emphasizes still remaining challenges. The competition between using different nanoplatforms, such as liposome-, hydrogel-, polymer-, silica nanosphere-, or nanosponge-based delivery systems is still “on” and no clear frontrunner has emerged to date.
Peptide drug, nanodelivery, physiological barriers, toxicity, immunogenicity, therapeutic peptides.
Department of Chemistry, Kansas State University, 419 CBC Building, Manhattan, KS 66506-0401, Department of Chemistry, Kansas State University, 419 CBC Building, Manhattan, KS 66506-0401, Department of Chemistry, Kansas State University, 419 CBC Building, Manhattan, KS 66506-0401